Vibegron
Vibegron
Vibegron (pronounced vi-BEG-ron) is a medication used in the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
Etymology
The name "Vibegron" is a proprietary name registered by the pharmaceutical company Urovant Sciences. The exact etymology is not publicly disclosed, but it is common for drug names to be created by combining parts of words that suggest the drug's medical category, mechanism of action, or other relevant characteristics.
Pharmacology
Vibegron is a Beta-3 adrenergic receptor agonist. It works by relaxing the bladder muscle during the storage phase of the bladder fill-void cycle, which helps increase the bladder's capacity to hold urine and reduces the symptoms of OAB.
Usage
Vibegron is used to treat adults with overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. It is taken orally, usually once a day.
Side Effects
Common side effects of Vibegron include headache, urinary tract infection, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection.
Related Terms
- Overactive bladder
- Urinary incontinence
- Urinary urgency
- Urinary frequency
- Beta-3 adrenergic receptor
- Urovant Sciences
External links
- Medical encyclopedia article on Vibegron
- Wikipedia's article - Vibegron
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski